Matt DeNardo

speaker

183 appearances 1 recordings 1 series first heard Jul 2026 last heard 11 Jul

Matt DeNardo’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere · Matt DeNardo, Chief Product Officer at Axoft · 11 Jul 2026 podcast

For me, it definitely came from experience where

I think this is a pretty common career path where folks who tend to start off very technical are very much in the details of developing the technology and what its capabilities are.

what its specifications are and what's possible to do in engineering.

And I think for me, learning early on that just because you have a good technical solution doesn't mean that you have a product was a very important thing.

And being at an engineering consulting firm helped me see all these different approaches because at the engineering consulting firm, we were responsible for the technology.

And the overall product development, marketing, alignment with clinical need usually came from our clients.

So I saw across a broad spectrum of devices how we could solve technical issues, but knowing that they were the right solution to go after in the first place or that

the device was addressing the right clinical need was something that came from our clients.

And I saw both things that were really successful in doing that and things that weren't.

And for me, it kind of shaped how I think about technology development throughout my career, knowing that you need to integrate the

end user, the clinical need, and the patient into your thinking early on because otherwise you end up solving the wrong technical problem or bringing a solution to market that nobody wants.

So I think I had seen from engineering consulting that similar to what I just talked about, that a lot of the challenge was that as consultants, you only have so much control of the whole process.

And so I developed that kind of desire to want ownership of the complete solution, not just the technical solution.

And one of the things that specifically drew me to XSoft was that they were addressing a clinical need in brain-computer interfaces in a very unique way.

And that was by designing from the brain interface itself outward.

So they started with a material platform that the co-founder and CEO developed during his PhD work.

And to me, that struck me as just somebody who is really listening to what the industry needed and not just trying to throw technology at what they thought the problem was.

And so for me, that was something that differentiated Axsoft from other brain-computer interface companies.

And that type of thinking was something that really resonated with me.

That I knew that going to a company like Axsoft would lead to decisions being made in the technology development that were supported by the clinical need that we were trying to address.

Showing 21–40 of 183 · page 2 of 10